Cite
HARVARD Citation
Cottu, P. et al. (2020). Evolution in the real-world therapeutic strategies in more than 20, 000 women with breast cancer having received human epidermal growth factor receptor 2–targeted treatments: Results from the french personalized reimbursement model database (2011–2018). European journal of cancer. pp. 209-217. [Online].